LitAlert ~~ GeneLit.com

    • Lack of evidence for CDK12 as an ovarian cancer predisposing gene.
    • Eeckhoutte A, Saint-Ghislain M, Reverdy M, Raynal V, Baulande S, Bataillon G, Golmard L, Stoppa-Lyonnet D, Popova T, Houdayer C, Manié E, Stern MH.
    • Fam Cancer. 2020 Mar 14. doi: 10.1007/s10689-020-00169-2. [Epub ahead of print]
    • Delayed presentation, diagnosis, and psychosocial aspects of male breast cancer.
    • Co M, Lee A, Kwong A.
    • Cancer Med. 2020 Mar 13. doi: 10.1002/cam4.2953. [Epub ahead of print]
    • Poly(ADP-ribose) polymerase inhibitors as maintenance treatment in patients with newly diagnosed advanced ovarian cancer: a meta-analysis.
    • Ibrahim EM, Refae AA, Bayer AM, Sagr ER.
    • Future Oncol. 2020 Mar 13. doi: 10.2217/fon-2020-0057. [Epub ahead of print]
    • Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma.
    • Wolford JE, Bai J, Moore KN, Kristeleit R, Monk BJ, Tewari KS.
    • Gynecol Oncol. 2020 Mar 13. pii: S0090-8258(20)30176-1. doi: 10.1016/j.ygyno.2020.02.030. [Epub ahead of print]
    • Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy.
    • Liontos M, Sotiropoulou M, Kaparelou M, Tzannis K, Tsironis G, Kyriazoglou, Tsiara A, Zakopoulou R, Koutsoukos K, Zagouri F, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Bamias A.
    • Gynecol Oncol. 2020 Mar 12. pii: S0090-8258(20)30224-9. doi: 10.1016/j.ygyno.2020.03.008. [Epub ahead of print]
    • Clinical Effects of Early or Surgical Menopause.
    • Kingsberg SA, Larkin LC, Liu JH.
    • Obstet Gynecol. 2020 Mar 10. doi: 10.1097/AOG.0000000000003729. [Epub ahead of print]
    • Review